Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic region
about
Drug repurposing and human parasitic protozoan diseasesDiffering patterns of selection and geospatial genetic diversity within two leading Plasmodium vivax candidate vaccine antigens.Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages[Evaluation of liver function in severe malaria in children under five in Kinshasa, Democratic Republic of the Congo].Miniaturized Cultivation of Microbiota for Antimalarial Drug Discovery.Age-shifting in malaria incidence as a result of induced immunological deficit: a simulation study.How Should Antibodies against P. falciparum Merozoite Antigens Be Measured?Adjuvants containing natural and synthetic Toll-like receptor 4 ligands.Live attenuated pre-erythrocytic malaria vaccines.Clinical development of RTS,S/AS malaria vaccine: a systematic review of clinical Phase I-III trials.Discovery and Characterization of ACT-451840: an Antimalarial Drug with a Novel Mechanism of Action.Synthesis and antimalarial evaluation of amide and urea derivatives based on the thiaplakortone A natural product scaffold.Single-cell profiling of lineage determining transcription factors in antigen-specific CD4+ T cells reveals unexpected complexity in recall responses during immune reconstitution.[Hemogram profile of malaria in children 0-5 years under quinine--situation in the Democratic Republic of Congo].Synthesis, antimalarial properties, and SAR studies of alkoxyurea-based HDAC inhibitors.
P2860
Q26999453-28A081EC-9EC2-4725-9992-0DD367893786Q30439881-CCFDEFE5-3881-484D-90F6-AB2C0EDDD1F7Q35182742-69270186-1FB0-4D7A-B803-CB2ACD666750Q35347186-AA5CFF64-BD5B-4E1E-8358-C147E39005C2Q35535108-1C289E07-C48A-4547-B4DA-86A1DBF7FA33Q35885315-A4D1259E-BDAC-4703-B795-DFD2129261C5Q36838314-BD863AB9-2819-4EAF-BFCF-F855F8286DFBQ38124063-AAF749F9-DB2B-438F-9053-3CE5CB9CFA0CQ38284696-11256963-2AB9-4AA0-A9A8-4ACDB58263EAQ38599514-88C6D850-1A1B-4C20-93DD-AE0E2784F748Q38915797-80FAB679-30A4-4230-8086-613633ECC2F2Q38930568-BF5B6CA3-0319-429E-A15C-596E77FE9A5AQ40220390-5834D46A-9784-49B9-AE51-295B5820A4E4Q41916225-F7065D61-F17F-4625-8339-42AB4FDE764BQ42706975-2C96D73C-06AC-4214-9032-D79D7CAC4003
P2860
Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic region
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Randomized, controlled trial o ...... ng in a malaria-endemic region
@ast
Randomized, controlled trial o ...... ng in a malaria-endemic region
@en
type
label
Randomized, controlled trial o ...... ng in a malaria-endemic region
@ast
Randomized, controlled trial o ...... ng in a malaria-endemic region
@en
prefLabel
Randomized, controlled trial o ...... ng in a malaria-endemic region
@ast
Randomized, controlled trial o ...... ng in a malaria-endemic region
@en
P2093
P2860
P50
P356
P1433
P1476
Randomized, controlled trial o ...... ng in a malaria-endemic region
@en
P2093
Ali Mohammed
Amanda Leach
David Schellenberg
Francisca Machera
Grace Mwangoka
Johan Vekemans
Marc Lievens
Marie-Claude Dubois
Mwanajaa Shomari
P2860
P2888
P356
10.1186/1475-2875-12-11
P577
2013-01-08T00:00:00Z
P5875
P6179
1045582687